Use este identificador para citar ou linkar para este item:
Título: Low-Dose naltrexone in diseases’ treatment : global review
Autor(es): Moura, Felipe Carmo de
Martins, Conceição da Silva
Soares, Paula Matias
Brito, Gerly Anne de Castro
Palavras-chave: Naltrexona
Antagonistas de Entorpecentes
Narcotic Antagonists
Data do documento: Fev-2016
Editor: Research Inventy: International Jou rnal o f Engineering And Science
Citação: MOURA, F. C. ; MARTINS, C. S. ; SOARES, P. M. ; BRITO G. A (2016)
Abstract: ABSTRACT – Naltrexone is a non - selective opioid antagonist, which shows effects on delta, mu and kappa rece ptors. Its therapeutic use is designed for drug addicts’ treatment, reducing withdrawal side effects. However, several researchers have used low - dose Naltrexone (LDN) for therapeutic purposes in diseases associated to immune system deficiency and inflammat ory and tumor processes. Consequently , enhance evidences that LDN use hypothesis promotes, through a compensation mechanism, an increase of endorphins and enkephalins, in addition to opioid receptors up - regulation mechanis m, in Central Nervous System (CNS) , becoming it a potentially effective clinical practice in these pathologies. Thus, we present a review about LDN use in different pathologies, all they published in literature, and its therapeutic effects, enabling us to conclude that 3.0 - 4.5mg/day dose u se in humans is effective for idiopathic diseases with alterations in immune system, as well as those ones with inflammatory and tumor characteristics
Descrição: MOURA, Felipe Carmo de et al. Low-Dose naltrexone in diseases' treatment : global review. Research Inventy: International Journal of Engineering And Science, v. 6, n. 2, p. 1-4, feb., 2016.
ISSN: (p):2319 - 6483
(e): 2278 - 4721
Aparece nas coleções:DFIFA - Artigos publicados em revista científica

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
2016_art_fcmoura.pdf453,1 kBAdobe PDFVisualizar/Abrir

Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.